Annual USC Update in GI and Liver Disease: Controversies and Guidelines in 2024

Friday, September 13, 2024, 3:00 PM - Saturday, September 14, 2024, 3:45 PM, Sheraton San Gabriel, San Gabriel, CA

AMA PRA Category 1 Credits™ (9.25 hours), Non-Physician Attendance (9.25 hours)

Pre-registration for this program is now closed. To register after September 9th, please visit the registration desk at the Sheraton San Gabriel Los Angeles on September 13th starting at 3pm and September 14th starting at 7:30 am. Thank you!

The diagnosis and treatment of gastrointestinal and liver diseases have rapidly evolved, significantly altering patient care approaches. New pharmacological developments have revolutionized the management of Crohn's disease, ulcerative colitis, and viral hepatitis. Additionally, advancements in endoscopic and imaging techniques have reshaped our diagnostic and therapeutic strategies for pancreaticobiliary diseases, motility disorders, and early luminal neoplasia. These changes have created a knowledge gap in current patient treatment methodologies. This conference aims to update community standards of practice, covering cancer screening guidelines, obesity management, and various topics in luminal, pancreatic, and liver diseases. It emphasizes the latest advancements in Gastroenterology and Hepatology, which hold the potential to enhance patient care.

1. Identify advances in third-space endoscopy and complicated biliary cases.
2. Explain the role of supportive techniques in the evaluation of esophageal disorders and how best to evaluate belching, bloating, distention, and other common GI symptoms.
3. Review updates in the medical management of IBD and the management of dysplasia.
4. Outline the newest screening and surveillance approaches for colorectal and pancreatic cancer.
5. Describe the evaluation process for both living liver donors and recipients, encompassing medical, surgical, and patient perspectives, to ensure optimal outcomes and minimize risks associated with living donor liver transplants.
6. Recognize the pathophysiology and clinical implications of acute kidney injury in cirrhosis, including its impact on patient prognosis and management strategies, to improve early detection and treatment approaches in clinical practice.
7. Review the latest advancements in treatments for hepatocellular carcinoma (HCC), including surgical, locoregional, and systemic therapies.
8. Describe methods to optimize the care of the ambulatory patient with cirrhosis and prevent decompensation.
9. Discover insights into recent advances in managing metabolic dysfunction associated with steatohepatitis (MASH), including pharmacological and lifestyle interventions, to address the growing burden of MASH-related liver disease and improve patient outcomes.
10. Examine the latest developments in hepatitis B treatment, including antiviral therapies.

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 9.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Cancellation Policy

Cancellations must be received by the USC Office of CME by fax or email by September 9. 20234 by 12:00 pm PDT for a refund. A $50 cancellation fee will be applied. In the event of course cancellation by conference organizers, all registration fees will be fully refunded. USC will not refund any travel costs incurred.


Accessibility Statement
 
Keck School of Medicine Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodations, including dietary concerns, please contact the USC Office of CME at [email protected].

The registration form for this activity is currently unavailable.

Click here to access the room block at the Sheraton Los Angeles San Gabriel for $189 per night plus tax. The block closes on August 16th, 2024. 

The Keck School of Medicine Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Keck School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.